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SUMMARY

Sox2
+ adult mouse pituitary cells can self-renew and terminally differentiate in vitro, but their physiological role in vivo and possible contribution to oncogenesis remain largely unknown. Using genetic lineage tracing, we show here that the Sox2 + cell compartment of both the embryonic and adult pituitary contains stem/progenitor cells that are able to differentiate into all hormone-producing lineages and contribute to organ homeostasis during postnatal life. In addition, we show that targeted expression of oncogenic b-catenin in Sox2 + cells gives rise to pituitary tumors, but, unexpectedly, the tumor mass is not derived from the Sox2 + mutation-sustaining cells, suggesting a paracrine role of Sox2 + cells in pituitary oncogenesis. Our data therefore provide in vivo evidence of a role for Sox2
+ stem/progenitor cells in long-term physiological maintenance of the adult pituitary, and highlight an unexpected noncell-autonomous role for these cells in the induction of pituitary tumors.
INTRODUCTION
Somatic stem cells have been identified in numerous organs, where they play a critical role in normal tissue homeostasis and regenerative capacity after insult (Barker et al., 2012; Oshimori and Fuchs, 2012; Reya and Clevers, 2005; Rosen and Jordan, 2009; van Amerongen et al., 2012) , and are often involved in tumorigenesis Visvader and Lindeman, 2012) . Somatic stem cells specifically targeted with oncogenic genetic mutations were shown to generate tumors in a cellautonomous manner in several mouse models (Barker et al., 2009; Zhu et al., 2009 ). This finding has promoted the cancer stem cell paradigm, which holds that tumors contain cells that are able to self-renew and differentiate into other cells that populate the tumor mass Driessens et al., 2012; Schepers et al., 2012) . Whether somatic stem cells can contribute to oncogenesis in a different manner is not known.
The anterior pituitary (AP) serves as a major regulator of mammalian physiology by secreting endocrine factors that control many physiological processes, including growth, reproduction, metabolism, and stress. Comprising the anterior and intermediate lobes (AL and IL, respectively) , the AP has a developmental origin in Rathke's pouch (RP), a region of the oral epithelium that is specified at $9.0 days postcoitum (dpc) in the mouse embryo (Kelberman et al., 2009; Mollard et al., 2012) . Proliferation of RP embryonic precursors generates a pool of undifferentiated progenitors, which upon exiting the cell cycle initiate commitment into specific cell lineages (e.g., Pit1 and Tpit, also known as Pou1f1 and Tbx19, respectively) and eventually terminally differentiate into the major AP cell types by late gestation (Bilodeau et al., 2009; Davis et al., 2011) . These cell types include growth hormone (GH)-secreting somatotrophs; prolactin (PRL)-secreting lactotrophs; thyroid stimulating hormone (TSH)-secreting thyrotrophs; adrenocorticotrophic hormone (ACTH)-secreting corticotrophs; gonadotrophs, which secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH); and melanotrophs, which secrete melanocytestimulating hormone (MSH) . Although all of the differentiated hormone-secreting cells are present before birth, the organ continues to develop postnatally, with a dramatic expansion of different cell populations at variable rates (Carbajo-Pé rez and Watanabe, 1990; Taniguchi et al., 2002) . Currently, it is not known whether pituitary stem cells contribute to normal organ homeostasis in postnatal life.
The transcription factor Sox2 is expressed in the AP anlage and its essential role in normal pituitary development has been demonstrated by tissue-specific conditional deletion (Fauquier et al., 2008; Jayakody et al., 2012) . Sox2 is required for the maintenance of stem cell populations in a range of tissues and is expressed in a population of cells in the adult pituitary gland that have several characteristics of stem cells (Arnold et al., 2011; Castinetti et al., 2011; Fauquier et al., 2008; Pevny and Rao, 2003) . This putative stem cell population, which can self-renew and differentiate into all hormone-producing cell types in vitro, is only a subset of all pituitary Sox2 + cells Gaston-Massuet et al., 2011) . Quantitative studies have shown that these cells are most abundant in the early postnatal pituitary and regress as the major postnatal expansion of the gland occurs, but a Sox2 + cell population with in vitro stem cell characteristics remains in the adult mouse (Gaston-Massuet et al., 2011; Gremeaux et al., 2012) . Recent studies of cell ablation of differentiated cell types have suggested a potential role for these adult Sox2 + cells in tissue regeneration, but in the absence of lineage tracing tools, their contribution could not be defined . A further characteristic of the AP gland is its propensity to form benign but often locally infiltrative tumors, with evidence for pituitary adenomas in 6%-24% of human adults (Gueorguiev and Grossman, 2011; Melmed, 2011) . Functional adenomas are characterized by the expansion of one or more of the hormone-producing cell types, in contrast to null-cell adenomas, which do not express any hormone. Studies of human biopsies have demonstrated the presence of stem-like cells in pituitary tumors, as well as in mice (Florio, 2011; Gleiberman et al., 2008) . Recently, expression of a degradation-resistant mutant form of b-catenin (encoded by Ctnnb1) that leads to overactivation of the WNT pathway in embryonic pituitary precursors of Hesx1
Cre/+ ;Ctnnb1 lox(ex3)/+ mice was shown to cause the formation of tumors resembling human adamantinomatous craniopharyngioma (ACP) (Gaston-Massuet et al., 2011) . These pediatric tumors are associated with somatic overactivating mutations in CTNNB1 and despite being histologically benign, ACPs are locally invasive, resulting in significant morbidity and mortality (Buslei et al., 2005; Mü ller, 2010 The Sox2 + cell compartment in the adult and embryonic pituitary has been extensively explored in various studies Fauquier et al., 2008; Gremeaux et al., 2012) . These studies demonstrated that the vast majority of the Sox2 + cells are undifferentiated and do not express markers of cell-lineage commitment or differentiation. We reexamined this notion using the Sox2-eGFP mouse line, in which Sox2 + cells are marked by enhanced GFP (eGFP) expression (Ellis et al., 2004) . Double immunofluorescence showed that essentially all GFP + cells costained for nuclear SOX2 and none of the GFP + cells were positive for any marker of cell-lineage commitment or terminal differentiation ( Figures S2A-S2C) . It was previously shown that there is a significant degree of overlap between SOX2 and S100B expression in cells from the adult mouse (Fauquier et al., 2008) and rat pituitary (Yoshida et al., 2011) . S100B labels folliculostellate (FS) cells in the AP, a heterogeneous cell population of non-hormoneproducing cells that are involved in regulating AP function by secreting diverse signaling molecules and have been proposed to contain undifferentiated progenitors (Allaerts et al., 1990; Devnath and Inoue, 2008) . Expression analyses of the S100B-eGFP transgenic line, which expresses eGFP in S100B + cells (Vives , and terminal differentiation of hormone-producing cells (aGSU, PRL, GH, TSH, LH, and ACTH). Scale bars, 100 mm (C) and 50 mm (E). See also Figure S1 . CreERT2/+ ;R26 YFP/+ were injected intraperitoneally once with a single high dose of tamoxifen (0.3 mg/g) and the pituitary was analyzed 24 hr postinduction. Double immunostaining against Cre and SOX2 revealed a widespread colocalization of the two proteins, demonstrating that CreERT2 expression was restricted to the Sox2 + cell compartment of the pituitary gland, even when induction was carried out with a high dose of tamoxifen ( Figure S3A ). YFP + cells were abundantly detected from 30 hr postinduction, mostly coexpressing SOX2. In these pituitaries, colocalization of YFP and hormones was very rare, as assessed using a pan-hormonal cocktail of antibodies against GH, PRL, TSH, ACTH, aGSU, LH, and FSH (0.5%, n = 4 pituitaries). Costaining of PIT1, a cell-lineage marker that is required for differentiation of adult somatotrophs, lactotrophs, and thyrotrophs (Li et al., 1990) , and YFP was observed occasionally ($5% of YFP + cells; Figure 3A ). Similar results were obtained in Sox2 CreERT2/+ ;R26 YFP/+ mice induced at 7 months of age (data not shown). To investigate whether these populations arise through rapid differentiation of Sox2 + cells or coexpress SOX2, we carried out triple immunostaining against SOX2, YFP, and either hormones or PIT1. No cells were observed to be double labeled with SOX2 and commitment/differentiation markers, confirming that the observation of targeted committed/differentiated cells after 30 hr is due to rapid commitment of a proportion of targeted Sox2 + progenitors ( Figure 3 ). Together, these data demonstrate that tamoxifen induction results in the activation of CreERT2 and expression of YFP in Sox2 + cells, including S100B + FS cells, which do not express hormones. However, Sox2 + cells can rapidly initiate differentiation by activating cell-lineage commitment markers such as PIT1, which precede terminal differentiation of hormone-producing cells.
Cell Stem Cell
We previously demonstrated that in vitro clonogenic potential is exclusively retained within the Sox2 + cell population of the AP; however, only $2.4% of these cells are capable of self-renewal and clonal expansion when cultured in stem-cell-promoting media . To further validate the efficiency of the genetic approach, the APs of Sox2 CreERT2/+ ;R26 YFP/+ tamoxifen-induced mice (n = 4) were dissected 48 hr postinduction and dissociated into single-cell suspensions. YFP + cells
were then isolated by flow sorting and cultured in stem-cell-promoting media at clonal density ( Figure 4C ). Most of the colonyforming cells (94.2%) were included in the YFP + , suggesting that the genetic approach and induction protocol labeled a significant proportion of the Sox2 + population with clonogenic potential. When these colonies were grown in differentiation conditions, in the absence of growth factors, they downregulated progenitor marker expression (Sox2, Sox9, and Nestin) and upregulated the transcription of typical markers of cell-lineage commitment and differentiation (Pit1, Pomc1, Tsh, and Gh; Figure S4A ). CreERT2/+ ;R26 YFP/+ animals at 4-6 weeks of age (young adults) with a single dose of 0.15 mg tamoxifen per gram of body weight and analyzed the pituitaries after 48 hr and for up to 1 year. We found that at 48 hr, the majority of YFP + cells coexpressed SOX2 (92%, 94%, and 96%; n = 3 pituitaries). After 9 months, we found abundant coexpression of YFP with markers of terminal differentiation, including GH, PRL, TSH, ACTH, aGSU, FSH, and LH, demonstrating that derivatives of the tamoxifen-targeted Sox2 + cells had contributed to all pituitary cell lineages ( Figures 4A and S4B ). Of note, the contribution to TSH-expressing cells was very low, perhaps suggesting a low cell turnover of thyrotrophs. In addition, YFP + cells expressing SOX2, SOX9, or S100B were evident in these animals, demonstrating that the initially labeled cells were not short-lived progenitors, but rather were long-lived stem cells ( Figures 2D, 4A , and S4B). However, the degree of colonization by Sox2 + descendants was rather limited at all stages analyzed (1-, 6-, 9-, and 12-month intervals; n = 5, 4, 3, and 3, respectively; Figure 4B) , in accordance with low cell turnover of the pituitary gland under physiological conditions (Florio, 2011; Levy, 2008) especially when compared with the initial population of YFP+ cells observed after 48 hr and 1 week ( Figure 4B ). YFP + cells appeared to be mostly solitary and were rarely observed in small groups after 9 and 12 months of tracing. Similar results were obtained when 3-and 6-month-old adult Sox2
CreERT2/+ ;R26 YFP/+ mice were induced with tamoxifen and traced for up to 6 months, suggesting that multipotent Sox2
+ cells are present throughout adult life (data not shown).
Next, we sought to assess whether YFP + cells coexpressing SOX2, which persisted in the pituitary of traced animals, have clonogenic potential in vitro ( Figure 4C (Hofmann et al., 2006) . The cluster cells were quiescent or slowly dividing, as they did not express the proliferation-associated marker Ki67 ( Figure 5C ). In addition, these clusters contained undifferentiated cells, as evidenced by the lack of expression of the differentiation or commitment markers aGSU and PIT1, respectively ( Figure S5C ). SOX2 expression was observed in sporadic cells within the small clusters, whereas SOX9 was mostly not expressed in small clusters but was often detected in the periphery of larger ones ( Figure 5C ). As expected, activation of the WNT pathway occurred in b-catenin-accumulating cell clusters, as demonstrated by the expression of the WNT targets Axin2 and Lef1 (Figures 5B and S5A ; Jho et al., 2002; Wu et al., 2012) . We observed the expression of these markers in the periphery of some large cell structures concomitantly with b-catenin accumulation. (Figure 5D ). The pituitary glands of the remaining mice (two out of eight), as well as those of animals analyzed 2-3 months postinduction (five out of seven), appeared normal by gross morphology but contained small tumors upon histological analysis. The observed tumors were well circumscribed and contained densely packed cells and some mitotic nuclei. AL -induced pituitaries. Note the darker staining in the small clusters and periphery of the larger ones. In situ hybridization shows that these cluster cells activate the WNT pathway, as evidenced by the activation of the WNT/b-catenin target Axin2, and express Wnt5a, Wnt6, Wnt10a, Shh, Bmp4, and Fgf3, the products of which are secreted signaling molecules. Expression of these markers is also stronger in the small clusters (arrowheads) and often in the periphery of the larger ones (arrows). 
Sox2 + Pituitary Stem Cells Induce Tumors pituitary tissue was evident around the tumors and the IL and PL were also apparently normal. Immunohistochemistry revealed the absence of staining using antibodies against PIT1, GH, PRL, TSH, ACTH, and a-GSU within the tumors, but positive cells were detectable around the lesions, confirming the presence of unaffected pituitary tissue ( Figure 5E ). Null-cell adenomas are pituitary tumors characterized by the lack of any hormone expression but positivity for the neural and endocrine cell marker synaptophysin. However, Sox2
CreERT2/+ ;Ctnnb1 lox(ex3)/+ pituitary tumors were synaptophysin negative, although staining was present in the surrounding pituitary tissue ( Figure 5D ). Analysis of b-catenin expression revealed a complex pattern within the tumor lesions, with some cells showing nuclear and/or cytoplasmic staining and others exhibiting normal membrane staining, such as the staining observed in unaffected pituitary cells around the lesions (Figures S5D and S5E ). Finally, expression of the cell-proliferation marker Ki67 was consistently observed within the lesions ( Figure S5D ). to enable lineage tracing of the descendants of the targeted Sox2 + cells through YFP expression. Mice were induced by two injections of low-dose tamoxifen at 6 weeks of age and traced for 3-5 months, when the pituitary was analyzed. As expected, these animals developed clearly identifiable, well-circumscribed tumor lesions, which were morphologically identical to those observed in Sox2
CreERT2/+ ; Ctnnb1 lox(ex3)/+ mice (Figure 6A) . The tumors were of variable size, possibly reflecting temporally different stages of development. Intriguingly, specific immunohistochemistry revealed that the vast majority of the cells within the tumors did not express YFP (n = 7 pituitaries and 23 individual tumor lesions; Figure 6 ). Abundant YFP + cells, some of which formed clusters, were identified in histologically normal pituitary tissue adjacent to the YFP À tumors, indicating that the lack of YFP detection was not due to inefficient tamoxifen induction and that an expansion of the Sox2 + cell lineage had occurred after Ctnnb1 activation ( Figures 6A-6C ).
We reasoned that the absence of YFP expression could be caused by different mechanisms, including (1) unequal Cremediated excision of the ROSA26 and Ctnnb1 loci, leading to recombination of only Ctnnb1-lox(ex3), but not ROSA26-floxstop-YFP, and hence expression of mutant b-catenin but not YFP; (2) a change of fate of the cells upon expression of mutant b-catenin, resulting in low or no expression of YFP; and (3) silencing of the locus through epigenetic changes or gene deletion. However, PCR analysis of DNA isolated from laser-capture microdissected tumors with specific primers to detect the different alleles revealed that neither the ROSA26 nor the Ctnnb1 loci had been excised, and both wild-type and floxed (nonrecombined) alleles were present ( Figure S6 ). This analysis argues against any of the possibilities outlined above and demonstrates that the tumors were not derived from the b-catenin-accumulating cells.
Immunostaining against b-catenin showed a heterogeneous patterning of expression in the tumor cells, with only some cells showing strong nucleocytoplasmic accumulation ( Figure 6B ). This expression pattern was also observed upon in situ hybridization with Lef1, indicating that the accumulation of b-catenin and WNT pathway activation was restricted to some of the tumor cells ( Figure 6B ). Because tumor cells do not contain the recombined Ctnnb1 allele, with ensuing expression of mutant b-catenin, these results suggest that the heterogeneous nucleocytoplasmic accumulation of b-catenin and activation of the WNT pathway in the tumors is non-cell-autonomous, and may be caused by secreted WNT ligands from nearby clusters. In agreement with this notion, Wnt5a, Wnt6, and Wnt10a were also found to be expressed in the b-catenin-accumulating cell clusters in induced Sox2
CreERT2/+ ; Ctnnb1 lox(ex3)/+ mice ( Figures   5B and S5B ). YFP À tumors were often observed developing in proximity to groups of YFP + cells that showed strong nucleocytoplasmic b-catenin accumulation (arrowheads in Figure 6B ), sometimes resembling the cell clusters observed after tamoxifen induction in Sox2
CreERT2/+ ;Ctnnb1 lox(ex3)/+ embryos (Figures 5B and 5C ; arrowheads in Figure 6C ). Occasionally, we observed that areas of YFP + and YFP À cells were found adjacent to each other, mostly in small tumors, suggesting that growth of the tumor cells (YFP À ) may require close proximity to the YFP + cells at initial stages of development ( Figure 6C , bottom panel). Immunostaining for the endothelial marker endomucin revealed a clear association of the clusters with blood vessels ( Figure 7A ). Most of the cells in these clusters were positive for S100B, suggesting that they most likely derived from Sox2 + ;S100B + cells, and many cells within the clusters were also positive for p75(NTR), another marker of FS cells ( Figure 7B ; Borson et al., 1994) . Components of the extracellular matrix (ECM), such as laminin and fibronectin, or integrin-bI associated with ECM proteins, were not enriched in or immediately surrounding the b-catenin-accumulating clusters. However, a slight enhancement of collagen type I was evident ( Figure S7 ). Together, these results demonstrate that a proportion of the Sox2 + population, possibly those expressing S100B, can be stimulated to expand in vivo to form clusters, but the tumors that are induced in the Sox2 CreERT2/+ ; Ctnnb1 lox(ex3)/+ mice are not derived from the Sox2 + cells that sustain the tumor-initiating mutation in Ctnnb1.
DISCUSSION
The possible contribution of Sox2 + cells to normal organ homeostasis has been controversial, since fully differentiated pituitary cells can divide postnatally. In this study, we show that Sox2 + cells are multi-or unipotent progenitors, or whether they selfrenew in vivo. However, a recent study using a similar mouse model demonstrated that the Sox2 + compartment contains stem cells in several organs, including the stomach, testes, and lens, and that these cells derive from Sox2 + embryonic precursors (Arnold et al., 2011; Sarkar and Hochedlinger, 2013) . In addition, Sox2 + cells are multipotent and can self-renew in vitro ( Figure 2C ; Andoniadou et al., 2012; Fauquier et al., 2008; Gaston-Massuet et al., 2011; Gremeaux et al., 2012) . The degree of Sox2 + stem cells' contribution to normal cell turnover appears to be limited, and even after year-long tracing, the majority of cells contained in these pituitaries were not derived from targeted Sox2 + cells. Genetic tracing of Lgr5 + or Prom1 + intestinal crypt stem cells has demonstrated a much higher degree of colonization of the gut villi by descendants of these cells (Barker et al., 2009; Zhu et al., 2009 ). However, gut epithelial cells renew every 4-5 days, whereas the pituitary gland requires up to 70 days to replace the constituent cells under normal physiological conditions (Florio, 2011; Levy, 2002; van der Flier and Clevers, 2009) . As our data demonstrate the efficient targeting of a large proportion of the Sox2 + cells, these results suggest that normal pituitary homeostasis results from a combination of Sox2 + progenitor/stem cells and the proliferation of fully differentiated cells and/or other progenitor populations (e.g., expressing Nestin or GFRa2) as previously proposed (Carbajo-Pé rez and Watanabe, 1990; Garcia-Lavandeira et al., 2009; Gleiberman et al., 2008; Taniguchi et al., 2002) . The expansion of Sox2 + -derived cells after activation of the WNT pathway, however, suggests that this Sox2+ cell population may be responsive to homeostatic signals within the pituitary (e.g., in repopulation after pathological challenge), with important implications for their therapeutic use (Castinetti et al., 2011). 
Cell Stem Cell
Sox2 + Pituitary Stem Cells Induce Tumors
We previously showed that the genetic expression of mutant b-catenin in committed or differentiated cells in the embryonic or adult pituitary using specific Cre lines (i.e., Gh-Cre, Prl-Cre, and Pit1-Cre) does not give rise to tumors, and proposed that progenitor/stem cells might have to be targeted to initiate the oncogenic process (Gaston-Massuet et al., 2011 ). An important finding of this study is that both embryonic and adult Sox2 A remarkable and unexpected result reported here is the discovery that mutagenized Sox2 + progenitor/stem cells drive tumor formation in a paracrine fashion. In previous studies, the and ROSA26-flox-stop-YFP alleles were used in combination with specific inducible Cre lines to investigate the role of adult somatic stem cells in tumors of the brain (Alcantara Llaguno et al., 2009; Jacques et al., 2010; Sutter et al., 2010) , gut (Barker et al., 2009; Zhu et al., 2009 ), pancreas (Gidekel Friedlander et al., 2009 ), prostate (Mulholland et al., 2009) , and skin (Youssef et al., 2010) . These studies demonstrated that mutation-sustaining stem cells are the cell-of-origin of these tumors (i.e., the tumor mass derives from the mutagenized stem cells), thus providing support for the notion that somatic stem cells can act in a cell-autonomous manner according to the cancer stem cell paradigm. Reciprocal cell signaling communication between tumor and normal cells is also important for oncogenesis, suggesting that somatic stem cells may be able to influence tumorigenesis in a non-cell-autonomous manner (Hanahan and Weinberg, 2011; Lathia et al., 2011; Nguyen et al., 2012; Visvader and Lindeman, 2012 (Figure 6 ). Moreover, we show that tumors contain cells in which the ROSA26 and Ctnnb1 loci have not been recombined ( Figure S6 ), which rules out the possibility that they are descendants of the b-catenin-accumulating cluster cells. Recently, a non-cell-autonomous effect of p53 was shown in a model of hepatocellular carcinoma, where p53-ablated hepatic stellate cells were able to induce tumors in a paracrine fashion (Lujambio et al., 2013) . Our data indicate that mutant b-catenin exerts a transient burst of proliferation in a proportion of Sox2 + cells that generate daughter cells, which form b-catenin-accumulating cell clusters. These clusters become quiescent and activate the expression of several secreted factors, such as Shh, Bmp4, Wnt5a, Wnt6, Wnt10a, and Fgf3 , that have important roles in tumorigenesis in both mice and humans (Labeur et al., 2010; Wesche et al., 2011; Yauch et al., 2008 Figure 6D . Pituitary adenomas are tumors with a significant prevalence, and although they are benign, they are associated with high morbidity due to both compression of nearby structures (i.e., the hypothalamus and visual pathways) and/or abnormal secretion of hormones. A minority of adenomas are syndromic/familial and the result of germline mutations for genes such as MEN1, AIP, and PRKAR1A or somatic mutations such as GNAS. However, the vast majority of pituitary adenomas are sporadic and the initial mutation that drives tumor formation remains generally elusive. Alterations in genes that are involved in syndromic adenomas, or in well-recognized tumor-suppressor genes or oncogenes that are commonly involved in other tumor types, have not been identified in the majority of sporadic adenomas (Dworakowska and Grossman, 2012; Melmed, 2011) . Our model may explain these results, as it predicts that the initial mutation that drives tumorigenesis occurs in a cell type that does not contribute cell autonomously to the tumor. This model establishes a framework for elucidating pituitary tumorigenesis and demonstrates a mechanism underlying pituitary tumorigenesis.
In summary, the results presented here exemplify the complex pathophysiology that governs pituitary oncogenesis in vivo, and extend our understanding of the role of somatic stem cells in Whether this mechanism is more generic and applicable to other tissues that contain somatic stem cells requires further investigation, with the exciting possibility of generating novel therapeutic targets in the treatment of primary and metastatic tumors.
EXPERIMENTAL PROCEDURES Mice
A detailed description of the generation of Sox2 CreERT2/+ mice is included in the Supplemental Experimental Procedures. The Ctnnb1-lox(ex3), Hesx1-Cre, ROSA26-flox-stop-YFP, Sox2-eGFP, and S100B-eGFP mice have been previously described (Andoniadou et al., 2007; Ellis et al., 2004; Harada et al., 1999; Srinivas et al., 2001; Vives et al., 2003 as a percentage of the total number of colonies. To assess differentiation potential, colonies were established in normal growth media for 5 days, followed by culture in differentiation conditions in the absence of growth factors and addition of 10% fibroblast-conditioned media for 2 weeks. S100B-eGFP APs from P9 animals were dissociated, flow sorted, and cultured as previously described (Gaston-Massuet et al., 2011) .
Histology, In Situ Hybridization, Immunostaining, and Microscopy Histology, in situ hybridization, immunostaining, and microscopy procedures were carried out as previously described GastonMassuet et al., 2011) . For a detailed list of the methods and antibody dilutions used, please see the Supplemental Experimental Procedures. For estimation of cell numbers, pituitaries (n = 3) were subjected to double immunofluorescence staining and five randomly selected fields were captured at 203 magnification. Between 500 and 1,000 YFP + cells were counted for each marker, including only those cells with visible nuclei. 
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